Catalog #CS10
Cagrilintide + Semaglutide
5 MG + 5 MG
Select Research Tier:
Batch-tested · Research-grade purity · Certificate of Analysis included
Quantity:
Line Total:
$130.00
Currently Out of Stock
This item is currently out of stock. You can still order — expect 7 to 10 business days for delivery.
Related Laboratory Supply
Laboratory Research Diluent — 0.9% Benzyl Alcohol is available separately for qualified laboratory workflows. Research use only. Not for human or animal use. Not for injection, diagnostic, clinical, therapeutic, or veterinary use.
View Laboratory Research Diluent →Technical Research Description
Cagrilintide + Semaglutide combination research investigates dual amylin and GLP-1 receptor activation. This pairing enables study of complementary mechanisms affecting appetite regulation, gastric emptying, and glucose homeostasis through distinct but overlapping pathways.
Simplified Explanation
This combination pairs two different appetite-regulating peptides. Cagrilintide mimics amylin while Semaglutide mimics GLP-1. Together, they target multiple pathways involved in hunger, digestion, and blood sugar control. Researchers study how these combined effects differ from single compounds.
For Research Use Only
DISCLAIMER: This product is sold for research purposes only. Not for human consumption.
By purchasing, you confirm that you are a qualified researcher or represent a research institution, and that this product will be used solely for in-vitro research or lawful scientific study.
Customer Reviews
No reviews yet — be the first to share your experience.
From Our Research Blog
Background reading and laboratory context for Cagrilintide + Semaglutide 5 MG + 5 MG — sourced from our research articles.
research
Cagrilintide + Semaglutide: Dual-Pathway Signals in Metabolic Research
Explore how cagrilintide + semaglutide is studied as an amylin/GLP-1 combination in metabolic research, including receptor biology…
Jun 16, 2026
research
Tirzepatide dual receptor mechanism: why it matters
A research-first tour of tirzepatide's GIP/GLP-1 agonism: signaling bias, beta-cell effects, appetite circuits, and experimental d…
Aug 3, 2026
research
"WOLVERINE" BPC-157 + TB-500: Combo Rationale
A research-first look at why pairing BPC-157 and TB-500 shows up in repair biology literature, plus practical readouts for lab stu…
Jul 29, 2026
research
Cagrilintide + Semaglutide: sinergias de señalización
Scientific overview of cagrilintide + semaglutide: AMY and GLP-1 signaling, key cellular routes, and how labs deploy them in precl…
Jun 16, 2026
research
What Is Cagrilintide? A Research Overview
Cagrilintide is a long-acting amylin analog studied in metabolic research. Explore its structure, receptor pathways, research mode…
Jun 6, 2026
research
Tirzepatide: A dual incretin tool for metabolic work
Tirzepatide is a dual GIP/GLP-1 receptor agonist used in preclinical metabolic studies. Here's what to measure, control, and compa…
Jul 16, 2026
